Institute of Immunobiology-led research has made a significant breakthrough in understanding how the body combats lung cancer ...

The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...

As discussed in the beginning, in some cases lung cancer can spread to other parts of the body such as the brain, liver, and ...

Lung Disease Therapeutics Market. The global lung disease therapeutics market is on an impressive growth trajectory, ...

The trials are evaluating an individualized neoantigen vaccine with Keytruda as an adjuvant therapy for non-small cell lung cancer.

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that abstracts related to lacutamab health-related quality of life and translational data from the ...

McGill University scientists have discovered that pregnancy may trigger a natural immunity to boost protection against severe ...

The CRISPR-SCD trial is the first clinical attempt to use a non-viral delivery approach to directly correct the sickle cell ...

Some people naturally have higher levels of proteins that protect them from COVID-19. New studies at Umeå University of our immune system may pave the way for more personalized treatments of both ...

Hundreds of people with a rare form of eye cancer in England will have access to a “pioneering” drug on the NHS, officials ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...